Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats.
D000081:Acetamides / Q000037:antagonists & inhibitors*; D000230:Adenocarcinoma / Q000139:chemically induced; D000814:Aniline Compounds / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001555:Benzene Derivatives / Q000494:pharmacology; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D003408:Cresols / Q000494:pharmacology*; D005260:Female; D005449:Fluorenes / Q000037:antagonists & inhibitors*; D006877:Hydroxamic Acids / Q000037:antagonists & inhibitors; D008113:Liver Neoplasms / Q000139:chemically induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009602:Nitrosamines / Q000037:antagonists & inhibitors; D051381:Rats; D013329:Structure-Activity Relationship; D013431:Sulfates / Q000494:pharmacology / Q000652:urine
D000081:Acetamides; D000814:Aniline Compounds; D000975:Antioxidants; D001555:Benzene Derivatives; D002273:Carcinogens; D003408:Cresols; D005449:Fluorenes; D006877:Hydroxamic Acids; D009602:Nitrosamines; D013431:Sulfates